Acute intermittent porphyria: Difference between revisions

No edit summary
No edit summary
Line 42: Line 42:
==References==
==References==
<references/>
<references/>
[[Category:Heme/Onc]]

Revision as of 02:22, 17 October 2015

Background

  • Related to defect(s) in heme synthesis causing a buildup of porphyrins
  • Autosomal dominant, but poor penetrance

Clinical Features

  • Hallmark is abdominal pain with otherwise negative workup
  • May develop neurological symptoms - paresthesias, weakness. May progress to bulbar involvement and need for respiratory support/intubation.

Triggers

  • Infection, metabolic stress
  • Carbohydrate deficiency
  • Tobacco, EtOH

Diagnosis

  • Unlikely to diagnose first episode in ED given rarity of disease
  • Can check spot urine porphobilinogen (PBG) - sendout at most hospitals

Management

  • Analgesia
  • Avoid offending meds
  • Glucose load
    • Decreases porphyrin production
    • Typical protocol is D10W 3-4 liters daily x 4 days
    • Risk of hyponatremia given significant free water load
  • Hemin
    • Decreases porphyrin production, significantly more potent than glucose
    • Recommended for most cases requiring hospitalization, or any with neurologic symptoms
    • 3-4 mg/kg daily for 4 days
    • Can cause significant infusion site phlebitis - minimize by reconstituting in 25% albumin; consider central venous administration
    • Very expensive - around $8000 per 313 mg vial

Disposition

  • Admit all but very minor attacks

See Also

External Links

http://www.porphyriafoundation.com/

References